Radnor Capital Management LLC lowered its holdings in Maximus, Inc. (NYSE:MMS - Free Report) by 20.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,260 shares of the health services provider's stock after selling 4,415 shares during the period. Radnor Capital Management LLC's holdings in Maximus were worth $1,288,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. V Square Quantitative Management LLC bought a new stake in Maximus during the third quarter worth about $25,000. Eastern Bank bought a new stake in Maximus during the fourth quarter worth $29,000. GAMMA Investing LLC grew its position in shares of Maximus by 150.6% in the 3rd quarter. GAMMA Investing LLC now owns 862 shares of the health services provider's stock valued at $80,000 after acquiring an additional 518 shares during the period. Ariadne Wealth Management LP bought a new stake in shares of Maximus in the 2nd quarter valued at about $90,000. Finally, Quarry LP lifted its stake in Maximus by 48.0% in the 3rd quarter. Quarry LP now owns 1,017 shares of the health services provider's stock valued at $95,000 after purchasing an additional 330 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other news, Director Raymond B. Ruddy bought 3,490 shares of the company's stock in a transaction on Thursday, December 12th. The stock was purchased at an average cost of $71.46 per share, for a total transaction of $249,395.40. Following the completion of the transaction, the director now owns 112,520 shares of the company's stock, valued at $8,040,679.20. This trade represents a 3.20 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Bruce Caswell purchased 3,500 shares of Maximus stock in a transaction dated Tuesday, December 17th. The shares were purchased at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the acquisition, the chief executive officer now owns 275,929 shares of the company's stock, valued at approximately $19,491,624.56. The trade was a 1.28 % increase in their position. The disclosure for this purchase can be found here. Insiders acquired 7,063 shares of company stock worth $502,017 over the last three months. Insiders own 1.40% of the company's stock.
Maximus Price Performance
Shares of NYSE:MMS traded up $0.29 during trading on Wednesday, reaching $77.77. 511,537 shares of the company traded hands, compared to its average volume of 604,904. The firm has a market capitalization of $4.69 billion, a PE ratio of 15.55 and a beta of 0.73. The company's 50 day moving average is $76.36 and its two-hundred day moving average is $84.75. Maximus, Inc. has a 52 week low of $69.72 and a 52 week high of $93.97. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 0.59.
Maximus Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Shareholders of record on Saturday, February 15th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 1.54%. Maximus's dividend payout ratio is currently 24.00%.
Wall Street Analyst Weigh In
A number of brokerages recently commented on MMS. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, December 27th. Raymond James raised Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price for the company in a report on Thursday, January 2nd.
Read Our Latest Stock Report on MMS
Maximus Company Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Further Reading
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.